Global Multiple Sclerosis Drugs Market Research Report 2016

October 2016 | 109 pages | ID: G8CA8EE834FEN
QYResearch

Abstracts

Notes:

Production, means the output of Multiple Sclerosis Drugs

Revenue, means the sales value of Multiple Sclerosis Drugs

This report studies Multiple Sclerosis Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

• Biogen
• Teva Pharmaceutical
• Merck KGaA
• Novartis
• Bayer
• Sanofi
• Acorda Therapeutics
• Questcor Pharmaceuticals

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Multiple Sclerosis Drugs in these regions, from 2011 to 2021 (forecast), like

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on consumption, market share and growth rate of Multiple Sclerosis Drugs in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Multiple Sclerosis Drugs Market Research Report 2016

1 MULTIPLE SCLEROSIS DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Multiple Sclerosis Drugs
1.2 Multiple Sclerosis Drugs Segment by Type
  1.2.1 Global Production Market Share of Multiple Sclerosis Drugs by Type in 2015
  1.2.2 Type I
  1.2.3 Type II
  1.2.4 Type III
1.3 Multiple Sclerosis Drugs Segment by Application
  1.3.1 Multiple Sclerosis Drugs Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Multiple Sclerosis Drugs Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Multiple Sclerosis Drugs (2011-2021)

2 GLOBAL MULTIPLE SCLEROSIS DRUGS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Multiple Sclerosis Drugs Production and Share by Manufacturers (2015 and 2016)
2.2 Global Multiple Sclerosis Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Multiple Sclerosis Drugs Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Multiple Sclerosis Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Multiple Sclerosis Drugs Market Competitive Situation and Trends
  2.5.1 Multiple Sclerosis Drugs Market Concentration Rate
  2.5.2 Multiple Sclerosis Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL MULTIPLE SCLEROSIS DRUGS PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Multiple Sclerosis Drugs Production and Market Share by Region (2011-2016)
3.2 Global Multiple Sclerosis Drugs Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Multiple Sclerosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Multiple Sclerosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Multiple Sclerosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Multiple Sclerosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Multiple Sclerosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Multiple Sclerosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Multiple Sclerosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL MULTIPLE SCLEROSIS DRUGS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Multiple Sclerosis Drugs Consumption by Regions (2011-2016)
4.2 North America Multiple Sclerosis Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Multiple Sclerosis Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Multiple Sclerosis Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Multiple Sclerosis Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Multiple Sclerosis Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Multiple Sclerosis Drugs Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL MULTIPLE SCLEROSIS DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Multiple Sclerosis Drugs Production and Market Share by Type (2011-2016)
5.2 Global Multiple Sclerosis Drugs Revenue and Market Share by Type (2011-2016)
5.3 Global Multiple Sclerosis Drugs Price by Type (2011-2016)
5.4 Global Multiple Sclerosis Drugs Production Growth by Type (2011-2016)

6 GLOBAL MULTIPLE SCLEROSIS DRUGS MARKET ANALYSIS BY APPLICATION

6.1 Global Multiple Sclerosis Drugs Consumption and Market Share by Application (2011-2016)
6.2 Global Multiple Sclerosis Drugs Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL MULTIPLE SCLEROSIS DRUGS MANUFACTURERS PROFILES/ANALYSIS

7.1 Biogen
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Multiple Sclerosis Drugs Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Biogen Multiple Sclerosis Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 Teva Pharmaceutical
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Multiple Sclerosis Drugs Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Teva Pharmaceutical Multiple Sclerosis Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 Merck KGaA
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Multiple Sclerosis Drugs Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Merck KGaA Multiple Sclerosis Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Novartis
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Multiple Sclerosis Drugs Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Novartis Multiple Sclerosis Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Bayer
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Multiple Sclerosis Drugs Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Bayer Multiple Sclerosis Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 Sanofi
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Multiple Sclerosis Drugs Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Sanofi Multiple Sclerosis Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 Acorda Therapeutics
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Multiple Sclerosis Drugs Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Acorda Therapeutics Multiple Sclerosis Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 Questcor Pharmaceuticals
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Multiple Sclerosis Drugs Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Questcor Pharmaceuticals Multiple Sclerosis Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview

8 MULTIPLE SCLEROSIS DRUGS MANUFACTURING COST ANALYSIS

8.1 Multiple Sclerosis Drugs Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Multiple Sclerosis Drugs

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Multiple Sclerosis Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Multiple Sclerosis Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL MULTIPLE SCLEROSIS DRUGS MARKET FORECAST (2016-2021)

12.1 Global Multiple Sclerosis Drugs Production, Revenue Forecast (2016-2021)
12.2 Global Multiple Sclerosis Drugs Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Multiple Sclerosis Drugs Production Forecast by Type (2016-2021)
12.4 Global Multiple Sclerosis Drugs Consumption Forecast by Application (2016-2021)
12.5 Multiple Sclerosis Drugs Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Multiple Sclerosis Drugs
Figure Global Production Market Share of Multiple Sclerosis Drugs by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Multiple Sclerosis Drugs Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Multiple Sclerosis Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Multiple Sclerosis Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Multiple Sclerosis Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Multiple Sclerosis Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Multiple Sclerosis Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Multiple Sclerosis Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Multiple Sclerosis Drugs Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Multiple Sclerosis Drugs Production of Key Manufacturers (2015 and 2016)
Table Global Multiple Sclerosis Drugs Production Share by Manufacturers (2015 and 2016)
Figure 2015 Multiple Sclerosis Drugs Production Share by Manufacturers
Figure 2016 Multiple Sclerosis Drugs Production Share by Manufacturers
Table Global Multiple Sclerosis Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Multiple Sclerosis Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Multiple Sclerosis Drugs Revenue Share by Manufacturers
Table 2016 Global Multiple Sclerosis Drugs Revenue Share by Manufacturers
Table Global Market Multiple Sclerosis Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Multiple Sclerosis Drugs Average Price of Key Manufacturers in 2015
Table Manufacturers Multiple Sclerosis Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Multiple Sclerosis Drugs Product Type
Figure Multiple Sclerosis Drugs Market Share of Top 3 Manufacturers
Figure Multiple Sclerosis Drugs Market Share of Top 5 Manufacturers
Table Global Multiple Sclerosis Drugs Production by Regions (2011-2016)
Figure Global Multiple Sclerosis Drugs Production and Market Share by Regions (2011-2016)
Figure Global Multiple Sclerosis Drugs Production Market Share by Regions (2011-2016)
Figure 2015 Global Multiple Sclerosis Drugs Production Market Share by Regions
Table Global Multiple Sclerosis Drugs Revenue by Regions (2011-2016)
Table Global Multiple Sclerosis Drugs Revenue Market Share by Regions (2011-2016)
Table 2015 Global Multiple Sclerosis Drugs Revenue Market Share by Regions
Table Global Multiple Sclerosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Multiple Sclerosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Multiple Sclerosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table China Multiple Sclerosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Multiple Sclerosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Multiple Sclerosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table India Multiple Sclerosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Multiple Sclerosis Drugs Consumption Market by Regions (2011-2016)
Table Global Multiple Sclerosis Drugs Consumption Market Share by Regions (2011-2016)
Figure Global Multiple Sclerosis Drugs Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Multiple Sclerosis Drugs Consumption Market Share by Regions
Table North America Multiple Sclerosis Drugs Production, Consumption, Import & Export (2011-2016)
Table Europe Multiple Sclerosis Drugs Production, Consumption, Import & Export (2011-2016)
Table China Multiple Sclerosis Drugs Production, Consumption, Import & Export (2011-2016)
Table Japan Multiple Sclerosis Drugs Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Multiple Sclerosis Drugs Production, Consumption, Import & Export (2011-2016)
Table India Multiple Sclerosis Drugs Production, Consumption, Import & Export (2011-2016)
Table Global Multiple Sclerosis Drugs Production by Type (2011-2016)
Table Global Multiple Sclerosis Drugs Production Share by Type (2011-2016)
Figure Production Market Share of Multiple Sclerosis Drugs by Type (2011-2016)
Figure 2015 Production Market Share of Multiple Sclerosis Drugs by Type
Table Global Multiple Sclerosis Drugs Revenue by Type (2011-2016)
Table Global Multiple Sclerosis Drugs Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Multiple Sclerosis Drugs by Type (2011-2016)
Figure 2015 Revenue Market Share of Multiple Sclerosis Drugs by Type
Table Global Multiple Sclerosis Drugs Price by Type (2011-2016)
Figure Global Multiple Sclerosis Drugs Production Growth by Type (2011-2016)
Table Global Multiple Sclerosis Drugs Consumption by Application (2011-2016)
Table Global Multiple Sclerosis Drugs Consumption Market Share by Application (2011-2016)
Figure Global Multiple Sclerosis Drugs Consumption Market Share by Application in 2015
Table Global Multiple Sclerosis Drugs Consumption Growth Rate by Application (2011-2016)
Figure Global Multiple Sclerosis Drugs Consumption Growth Rate by Application (2011-2016)
Table Biogen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biogen Multiple Sclerosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Biogen Multiple Sclerosis Drugs Market Share (2011-2016)
Table Teva Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Pharmaceutical Multiple Sclerosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Teva Pharmaceutical Multiple Sclerosis Drugs Market Share (2011-2016)
Table Merck KGaA Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck KGaA Multiple Sclerosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck KGaA Multiple Sclerosis Drugs Market Share (2011-2016)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Multiple Sclerosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Multiple Sclerosis Drugs Market Share (2011-2016)
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Multiple Sclerosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer Multiple Sclerosis Drugs Market Share (2011-2016)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Multiple Sclerosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi Multiple Sclerosis Drugs Market Share (2011-2016)
Table Acorda Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Acorda Therapeutics Multiple Sclerosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Acorda Therapeutics Multiple Sclerosis Drugs Market Share (2011-2016)
Table Questcor Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Questcor Pharmaceuticals Multiple Sclerosis Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Questcor Pharmaceuticals Multiple Sclerosis Drugs Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Multiple Sclerosis Drugs
Figure Manufacturing Process Analysis of Multiple Sclerosis Drugs
Figure Multiple Sclerosis Drugs Industrial Chain Analysis
Table Raw Materials Sources of Multiple Sclerosis Drugs Major Manufacturers in 2015
Table Major Buyers of Multiple Sclerosis Drugs
Table Distributors/Traders List
Figure Global Multiple Sclerosis Drugs Production and Growth Rate Forecast (2016-2021)
Figure Global Multiple Sclerosis Drugs Revenue and Growth Rate Forecast (2016-2021)
Table Global Multiple Sclerosis Drugs Production Forecast by Regions (2016-2021)
Table Global Multiple Sclerosis Drugs Consumption Forecast by Regions (2016-2021)
Table Global Multiple Sclerosis Drugs Production Forecast by Type (2016-2021)
Table Global Multiple Sclerosis Drugs Consumption Forecast by Application (2016-2021)